CERENOME, INC. Net Change in Cash
CERENOME, INC. (CNSY) reported Net Change in Cash of -$6.39 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2026-08-14
- CERENOME, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2026-03-31 was -$5.74M, a 158.58% decline year-over-year.
- CERENOME, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2025-03-31 was $9.79M.
- CERENOME, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was -$5.65M.
- CERENOME, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was -$5.40M, a 290.10% decline year-over-year.
- CERENOME, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2025 was $8.68M.
- CERENOME, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2024 was -$8.48M.
- CERENOME, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was -$9.57M.
- CERENOME, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$280.00K, a 102.78% decline from fiscal 2021.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$6.39M 10-Q · filed 2026-08-14 | ||||
| 2026-03-31 | -$5.74M 10-Q · filed 2026-05-15 | ||||
| 2025-12-31 | $8.68M 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | $13.21M 10-Q · filed 2025-10-30 | ||||
| 2025-06-30 | $2.16M 10-Q · filed 2026-08-14 | ||||
| 2025-03-31 | $9.79M 10-Q · filed 2026-05-15 | ||||
| 2024-12-31 | -$8.48M 10-K · filed 2026-03-12 | ||||
| 2024-09-30 | -$7.33M 10-Q · filed 2025-10-30 | ||||
| 2024-06-30 | -$3.64M 10-Q · filed 2025-08-14 | ||||
| 2024-03-31 | -$5.65M 10-Q · filed 2025-05-30 | ||||
| 2023-12-31 | -$9.57M 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | -$7.11M 10-Q · filed 2024-11-14 | ||||
| 2023-06-30 | -$7.22M 10-Q · filed 2024-08-14 | ||||
| 2023-03-31 | -$5.40M 10-Q · filed 2024-05-15 | ||||
| 2022-12-31 | -$280.00K 10-K · filed 2024-03-05 | ||||
| 2022-09-30 | $1.87M 10-Q · filed 2023-10-31 | ||||
| 2022-06-30 | -$310.00K 10-Q · filed 2023-08-14 | ||||
| 2022-03-31 | $2.84M 10-Q · filed 2023-04-20 | ||||
| 2021-12-31 | $10.05M 10-K · filed 2023-02-23 | ||||
| 2021-09-30 | $12.93M 10-Q · filed 2022-10-20 | ||||
| 2021-06-30 | $8.81M 10-Q · filed 2022-07-21 | ||||
| 2021-03-31 | $6.10M 10-Q · filed 2022-04-21 | ||||
| 2020-12-31 | -$9.25M 10-K · filed 2022-02-24 | ||||
| 2020-09-30 | -$9.97M 10-Q · filed 2021-10-21 | ||||
| 2020-06-30 | -$8.33M 10-Q · filed 2021-07-22 | ||||
| 2020-03-31 | -$1.53M 10-Q · filed 2021-04-22 | ||||
| 2019-12-31 | $12.29M 10-K · filed 2021-02-22 | ||||
| 2019-09-30 | $11.57M 10-Q · filed 2020-10-22 | ||||
| 2019-06-30 | -$327.00K 10-Q · filed 2020-08-10 | -$731.00K 10-Q · filed 2019-08-15 | |||
| 2019-03-31 | -$1.39M 10-Q · filed 2020-05-14 | ||||
| 2018-12-31 | -$4.92M 10-K · filed 2020-03-30 | ||||
| 2018-09-30 | -$3.38M 10-Q · filed 2019-11-14 | ||||
| 2018-06-30 | -$7.11M 10-Q · filed 2019-08-15 | ||||
| 2018-03-31 | -$4.28M 8-K · filed 2019-09-10 | ||||
| 2017-12-31 | -$2.69M 8-K · filed 2019-09-10 | ||||
| 2017-09-30 | -$7.70M 10-Q · filed 2018-11-14 | ||||
| 2017-06-30 | -$3.45M 10-Q · filed 2018-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |